Pine Valley Investments LTD Liability CO Arrowhead Pharmaceuticals, Inc. Transaction History
Pine Valley Investments LTD Liability CO
- $1.53 Trillion
- Q2 2024
A detailed history of Pine Valley Investments LTD Liability CO transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Pine Valley Investments LTD Liability CO holds 19,523 shares of ARWR stock, worth $390,069. This represents 0.03% of its overall portfolio holdings.
Number of Shares
19,523
Previous 19,511
0.06%
Holding current value
$390,069
Previous $558 Million
9.07%
% of portfolio
0.03%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding ARWR
# of Institutions
293Shares Held
91.7MCall Options Held
1.33MPut Options Held
549K-
Black Rock Inc. New York, NY15.7MShares$313 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$244 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$178 Million3.15% of portfolio
-
State Street Corp Boston, MA5.84MShares$117 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.14MShares$82.7 Million2.11% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.11B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...